1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Doxapram for the prevention and treatment of apnea in preterm infants
(
- Contribution to journal › Article
-
Mark
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants
(
- Contribution to journal › Article
-
Mark
Methylxanthine for preventing morbidity and mortality in preterm infants : a network meta-analysis
(
- Contribution to journal › Article
-
Mark
Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome
(
- Contribution to journal › Scientific review
-
Mark
Superoxide dismutase for bronchopulmonary dysplasia in preterm infants
(
- Contribution to journal › Scientific review
-
Mark
Methylxanthine for the prevention and treatment of apnea in preterm infants
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Clinical rating scales for assessing pain in newborn infants
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Methylxanthine for the prevention and treatment of apnea in preterm infants [Protocol]
(
- Contribution to journal › Article
-
Mark
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity
(
- Contribution to journal › Article